Pascal G Doornebosch
Papers
1
Total Citations
84
H-Index
1
About
Pascal G. Doornebosch is a leading colorectal surgeon whose research focuses on improving surgical outcomes through advanced intraoperative imaging and minimally invasive techniques. His most impactful work centers on preventing anastomotic leakage—a devastating complication in colorectal surgery—by using indocyanine green (ICG) near-infrared fluorescence to assess bowel perfusion. As principal investigator of the landmark AVOID trial, a multicentre, randomised, controlled phase 3 study published in 2024, he demonstrated that real-time perfusion assessment significantly reduces leakage rates, directly influencing surgical protocols worldwide. With over 84 citations for this pivotal paper alone, Doornebosch’s contributions have reshaped standards of care in minimally invasive colorectal procedures. His research bridges the gap between innovative technology and clinical practice, offering surgeons a reliable tool to make safer intraoperative decisions. Beyond this trial, his work continues to explore fluorescence-guided surgery and enhanced recovery pathways, cementing his reputation as a translational researcher dedicated to improving patient outcomes. For students and surgeons alike, Doornebosch exemplifies how rigorous clinical trials can transform surgical safety.
Research Focus
Key Achievements
Top Papers
- 1